Jacobs Levy Equity Management, Inc Marker Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.47 - $3.29 $46,992 - $105,174	-31,968 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.36 - $1.75 $505 - $651	-372 Reduced 1.15%	31,968 $46,000
Q3 2020 Nov 16, 2020	BUY	$1.5 - $2.2 $14,421 - $21,150	9,614 Added 42.3%	32,340 $49,000
Q1 2020 May 15, 2020	SELL	$1.59 - $3.35 $199,630 - $420,605	-125,554 Reduced 84.67%	22,726 $43,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $397,390 - $719,158	148,280 New	148,280 $427,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $135M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.